Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects

Adiponectin is an adipocyte-specific protein suggested to play a role in mediating the metabolic effects of obesity. In the present study, we investigated adiponectin mRNA levels in both visceral and subcutaneous abdominal adipose tissue (AT) from lean and obese subjects. Investigations on both “fre...

Full description

Saved in:
Bibliographic Details
Published inMolecular and cellular endocrinology Vol. 219; no. 1; pp. 9 - 15
Main Authors Lihn, Aina S, Bruun, Jens M, He, Gengsheng, Pedersen, Steen B, Jensen, Peter F, Richelsen, Bjørn
Format Journal Article
LanguageEnglish
Published Ireland Elsevier Ireland Ltd 30.04.2004
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Adiponectin is an adipocyte-specific protein suggested to play a role in mediating the metabolic effects of obesity. In the present study, we investigated adiponectin mRNA levels in both visceral and subcutaneous abdominal adipose tissue (AT) from lean and obese subjects. Investigations on both “fresh” fat biopsies and incubations of AT fragments were performed. Regional differences in the effects of the cytokine interleukin-1β (IL-1β) were investigated. Adiponectin gene expression was 33% lower in visceral AT than in subcutaneous AT of lean subjects ( P<0.05), and 28% lower in obese subjects, albeit non-significant ( P=0.3). In both lean and obese subjects adiponectin mRNA expression in incubated AT fragments was significantly lower in visceral AT than in subcutaneous AT (lean: P<0.01; obese: P<0.05). No difference was found in adiponectin mRNA levels in gluteal compared to abdominal subcutaneous AT. IL-1β suppressed adiponectin mRNA levels substantially in both subcutaneous and visceral AT. In conclusion, adiponectin gene expression is lower in visceral AT than in subcutaneous abdominal AT, suggesting subcutaneous AT to be more important for circulating adiponectin levels.
AbstractList Adiponectin is an adipocyte-specific protein suggested to play a role in mediating the metabolic effects of obesity. In the present study, we investigated adiponectin mRNA levels in both visceral and subcutaneous abdominal adipose tissue (AT) from lean and obese subjects. Investigations on both “fresh” fat biopsies and incubations of AT fragments were performed. Regional differences in the effects of the cytokine interleukin-1β (IL-1β) were investigated. Adiponectin gene expression was 33% lower in visceral AT than in subcutaneous AT of lean subjects ( P<0.05), and 28% lower in obese subjects, albeit non-significant ( P=0.3). In both lean and obese subjects adiponectin mRNA expression in incubated AT fragments was significantly lower in visceral AT than in subcutaneous AT (lean: P<0.01; obese: P<0.05). No difference was found in adiponectin mRNA levels in gluteal compared to abdominal subcutaneous AT. IL-1β suppressed adiponectin mRNA levels substantially in both subcutaneous and visceral AT. In conclusion, adiponectin gene expression is lower in visceral AT than in subcutaneous abdominal AT, suggesting subcutaneous AT to be more important for circulating adiponectin levels.
Adiponectin is an adipocyte-specific protein suggested to play a role in mediating the metabolic effects of obesity. In the present study, we investigated adiponectin mRNA levels in both visceral and subcutaneous abdominal adipose tissue (AT) from lean and obese subjects. Investigations on both 'fresh' fat biopsies and incubations of AT fragments were performed. Regional differences in the effects of the cytokine interleukin-1 beta (IL-1 beta ) were investigated. Adiponectin gene expression was 33% lower in visceral AT than in subcutaneous AT of lean subjects (P<0.05), and 28% lower in obese subjects, albeit non-significant (P=0.3). In both lean and obese subjects adiponectin mRNA expression in incubated AT fragments was significantly lower in visceral AT than in subcutaneous AT (lean: P<0.01; obese: P<0.05). No difference was found in adiponectin mRNA levels in gluteal compared to abdominal subcutaneous AT. IL-1 beta suppressed adiponectin mRNA levels substantially in both subcutaneous and visceral AT. In conclusion, adiponectin gene expression is lower in visceral AT than in subcutaneous abdominal AT, suggesting subcutaneous AT to be more important for circulating adiponectin levels.
Adiponectin is an adipocyte-specific protein suggested to play a role in mediating the metabolic effects of obesity. In the present study, we investigated adiponectin mRNA levels in both visceral and subcutaneous abdominal adipose tissue (AT) from lean and obese subjects. Investigations on both "fresh" fat biopsies and incubations of AT fragments were performed. Regional differences in the effects of the cytokine interleukin-1beta (IL-1beta) were investigated. Adiponectin gene expression was 33% lower in visceral AT than in subcutaneous AT of lean subjects (P < 0.05), and 28% lower in obese subjects, albeit non-significant (P = 0.3). In both lean and obese subjects adiponectin mRNA expression in incubated AT fragments was significantly lower in visceral AT than in subcutaneous AT (lean: P < 0.01; obese: P < 0.05). No difference was found in adiponectin mRNA levels in gluteal compared to abdominal subcutaneous AT. IL-1beta suppressed adiponectin mRNA levels substantially in both subcutaneous and visceral AT. In conclusion, adiponectin gene expression is lower in visceral AT than in subcutaneous abdominal AT, suggesting subcutaneous AT to be more important for circulating adiponectin levels.Adiponectin is an adipocyte-specific protein suggested to play a role in mediating the metabolic effects of obesity. In the present study, we investigated adiponectin mRNA levels in both visceral and subcutaneous abdominal adipose tissue (AT) from lean and obese subjects. Investigations on both "fresh" fat biopsies and incubations of AT fragments were performed. Regional differences in the effects of the cytokine interleukin-1beta (IL-1beta) were investigated. Adiponectin gene expression was 33% lower in visceral AT than in subcutaneous AT of lean subjects (P < 0.05), and 28% lower in obese subjects, albeit non-significant (P = 0.3). In both lean and obese subjects adiponectin mRNA expression in incubated AT fragments was significantly lower in visceral AT than in subcutaneous AT (lean: P < 0.01; obese: P < 0.05). No difference was found in adiponectin mRNA levels in gluteal compared to abdominal subcutaneous AT. IL-1beta suppressed adiponectin mRNA levels substantially in both subcutaneous and visceral AT. In conclusion, adiponectin gene expression is lower in visceral AT than in subcutaneous abdominal AT, suggesting subcutaneous AT to be more important for circulating adiponectin levels.
Adiponectin is an adipocyte-specific protein suggested to play a role in mediating the metabolic effects of obesity. In the present study, we investigated adiponectin mRNA levels in both visceral and subcutaneous abdominal adipose tissue (AT) from lean and obese subjects. Investigations on both "fresh" fat biopsies and incubations of AT fragments were performed. Regional differences in the effects of the cytokine interleukin-1beta (IL-1beta) were investigated. Adiponectin gene expression was 33% lower in visceral AT than in subcutaneous AT of lean subjects (P < 0.05), and 28% lower in obese subjects, albeit non-significant (P = 0.3). In both lean and obese subjects adiponectin mRNA expression in incubated AT fragments was significantly lower in visceral AT than in subcutaneous AT (lean: P < 0.01; obese: P < 0.05). No difference was found in adiponectin mRNA levels in gluteal compared to abdominal subcutaneous AT. IL-1beta suppressed adiponectin mRNA levels substantially in both subcutaneous and visceral AT. In conclusion, adiponectin gene expression is lower in visceral AT than in subcutaneous abdominal AT, suggesting subcutaneous AT to be more important for circulating adiponectin levels.
Author Bruun, Jens M
Jensen, Peter F
Richelsen, Bjørn
Lihn, Aina S
He, Gengsheng
Pedersen, Steen B
Author_xml – sequence: 1
  givenname: Aina S
  surname: Lihn
  fullname: Lihn, Aina S
  email: lihn@dadlnet.dk
  organization: Department of Endocrinology and Metabolism C, Aarhus Amtssygehus, Aarhus University Hospital, Tage Hansensgade 2, DK-8000 Aarhus C, Denmark
– sequence: 2
  givenname: Jens M
  surname: Bruun
  fullname: Bruun, Jens M
  organization: Department of Endocrinology and Metabolism C, Aarhus Amtssygehus, Aarhus University Hospital, Tage Hansensgade 2, DK-8000 Aarhus C, Denmark
– sequence: 3
  givenname: Gengsheng
  surname: He
  fullname: He, Gengsheng
  organization: Department of Endocrinology and Metabolism C, Aarhus Amtssygehus, Aarhus University Hospital, Tage Hansensgade 2, DK-8000 Aarhus C, Denmark
– sequence: 4
  givenname: Steen B
  surname: Pedersen
  fullname: Pedersen, Steen B
  organization: Department of Endocrinology and Metabolism C, Aarhus Amtssygehus, Aarhus University Hospital, Tage Hansensgade 2, DK-8000 Aarhus C, Denmark
– sequence: 5
  givenname: Peter F
  surname: Jensen
  fullname: Jensen, Peter F
  organization: Department of Surgical Gastroenterology L, Aarhus Kommunehospital, Aarhus University Hospital, DK-8000 Aarhus C, Denmark
– sequence: 6
  givenname: Bjørn
  surname: Richelsen
  fullname: Richelsen, Bjørn
  organization: Department of Endocrinology and Metabolism C, Aarhus Amtssygehus, Aarhus University Hospital, Tage Hansensgade 2, DK-8000 Aarhus C, Denmark
BackLink https://www.ncbi.nlm.nih.gov/pubmed/15149722$$D View this record in MEDLINE/PubMed
BookMark eNqFkU1r3DAQhkVJ6O6m_QG9BJ96szP68EqmpxCapLAkEJJLL0KWR6DFtjaSnbb_Plp2S6GH5DSHeZ6ReN8VORnDiIR8oVBRoOuLbTVYrBiAqIBXAOwDWVIlWamglidkCRx4KRnIBVmltAUAWTP1kSxoTUUjGVuSn5vwC2OBv3cRU_JhLIIrTOd3-SU7-bEYHu4uizxffLIYTX9YJiwmn9KM-1WPZizM2BWhxbxIc7vNbvpETp3pE34-zjPydP398eq23Nzf_Li63JRWiPVUNihaabmqW-YUum5tG-mUsmigYYrKes2lg7qpUSFzvOHGWKWk6xR2rWKKn5Gvh7u7GJ5nTJMe9n_tezNimJOWtBFMNPW7IKOUMxAig-dHcG4H7PQu-sHEP_pvbBmgB8DGkFJE9w8Bva9Gb3WuRu-r0cB1riY78j_H-slMOfIpGt-_aX47mJhTfPEYdbIeR4udjzlo3QX_hv0KSLCoJQ
CitedBy_id crossref_primary_10_1111_jpn_13802
crossref_primary_10_1016_j_metabol_2011_03_019
crossref_primary_10_1210_jc_2007_0397
crossref_primary_10_1016_j_tem_2016_03_012
crossref_primary_10_1016_j_metabol_2015_11_011
crossref_primary_10_1016_j_atherosclerosis_2007_06_027
crossref_primary_10_3390_nu14204324
crossref_primary_10_1089_dia_2014_0026
crossref_primary_10_3389_fendo_2015_00001
crossref_primary_10_1038_oby_2008_275
crossref_primary_10_1111_jpi_12257
crossref_primary_10_15171_npj_2017_19
crossref_primary_10_1016_j_bbi_2024_12_029
crossref_primary_10_1186_s12881_015_0174_1
crossref_primary_10_3390_nu15234858
crossref_primary_10_1038_ijo_2014_192
crossref_primary_10_1038_oby_2006_92
crossref_primary_10_1038_oby_2007_231
crossref_primary_10_1038_sj_ijo_0802883
crossref_primary_10_1007_s00125_008_1031_y
crossref_primary_10_1210_jc_2005_2786
crossref_primary_10_1515_jpm_2015_0259
crossref_primary_10_2527_2005_833565x
crossref_primary_10_1016_S1499_2671_06_01006_9
crossref_primary_10_1111_j_1365_2362_2008_02028_x
crossref_primary_10_1016_j_crvi_2006_03_020
crossref_primary_10_3390_medicina57070653
crossref_primary_10_1111_j_1365_2265_2010_03883_x
crossref_primary_10_1245_s10434_015_4432_4
crossref_primary_10_1292_jvms_15_0233
crossref_primary_10_1155_2012_678381
crossref_primary_10_1210_jc_2009_0980
crossref_primary_10_1038_sj_ijo_0803745
crossref_primary_10_1111_j_1365_2796_2004_01426_x
crossref_primary_10_3390_ijms18050959
crossref_primary_10_1210_jc_2005_2775
crossref_primary_10_1016_j_dld_2014_07_016
crossref_primary_10_2337_db08_1019
crossref_primary_10_1152_ajpendo_00419_2004
crossref_primary_10_1038_nutd_2017_10
crossref_primary_10_1371_journal_pone_0146840
crossref_primary_10_1016_j_jocd_2015_10_004
crossref_primary_10_1016_j_canlet_2012_11_038
crossref_primary_10_1016_j_bbrc_2013_07_034
crossref_primary_10_1186_1476_511X_10_11
crossref_primary_10_3390_ijerph17093287
crossref_primary_10_1016_j_hnm_2023_200210
crossref_primary_10_1038_oby_2007_80
crossref_primary_10_1016_j_bbalip_2015_02_003
crossref_primary_10_1186_s12917_019_2065_8
crossref_primary_10_1016_j_jcte_2021_100257
crossref_primary_10_1007_BF03345790
crossref_primary_10_1038_oby_2005_262
crossref_primary_10_3390_nu15173806
crossref_primary_10_1007_BF03347056
crossref_primary_10_1038_sj_hdy_6801089
crossref_primary_10_1007_BF03174067
crossref_primary_10_1007_s00125_005_0038_x
crossref_primary_10_1038_oby_2006_5
crossref_primary_10_1371_journal_pone_0103093
crossref_primary_10_1016_j_orcp_2019_09_006
crossref_primary_10_1002_jcb_21980
crossref_primary_10_1016_j_tvjl_2016_08_002
crossref_primary_10_1038_oby_2005_74
crossref_primary_10_5402_2011_592404
crossref_primary_10_1016_j_atherosclerosis_2010_03_022
crossref_primary_10_1016_j_metabol_2008_12_009
crossref_primary_10_1111_j_1440_1797_2008_01018_x
crossref_primary_10_2147_DMSO_S271509
crossref_primary_10_1002_art_40102
crossref_primary_10_1038_oby_2007_556
crossref_primary_10_1007_s00125_006_0335_z
crossref_primary_10_1210_jc_2006_1268
crossref_primary_10_1007_s10354_010_0781_6
crossref_primary_10_2217_imt_13_142
crossref_primary_10_1194_jlr_M600272_JLR200
crossref_primary_10_1016_j_cca_2007_04_006
crossref_primary_10_1007_s11695_008_9701_x
crossref_primary_10_1186_s12933_018_0734_8
crossref_primary_10_1016_j_ijgo_2008_10_006
crossref_primary_10_1038_ijo_2010_98
crossref_primary_10_1111_jgh_14778
crossref_primary_10_1016_j_gene_2019_03_070
crossref_primary_10_1016_j_molmed_2005_06_010
crossref_primary_10_2217_dmt_11_22
crossref_primary_10_1016_j_regpep_2009_04_010
crossref_primary_10_1016_j_jss_2008_09_007
crossref_primary_10_4161_adip_21756
crossref_primary_10_1016_j_diabet_2008_04_001
crossref_primary_10_1038_s41598_024_76280_6
crossref_primary_10_1152_ajpendo_90359_2008
crossref_primary_10_1016_j_peptides_2014_10_006
crossref_primary_10_3389_fendo_2024_1439691
crossref_primary_10_1038_ijo_2016_128
crossref_primary_10_1210_er_2012_1041
crossref_primary_10_1038_s41598_019_47113_8
crossref_primary_10_1517_14656560802618811
crossref_primary_10_1038_ncpgasthep0186
crossref_primary_10_1097_01_mco_0000172571_41149_52
crossref_primary_10_1161_STROKEAHA_108_520106
crossref_primary_10_1080_08820139_2024_2302823
crossref_primary_10_1507_endocrj_EJ14_0262
crossref_primary_10_1016_j_metabol_2008_07_029
crossref_primary_10_18087_cardio_2020_4_n517
crossref_primary_10_1038_sj_ijo_0803676
crossref_primary_10_1210_jc_2007_1155
crossref_primary_10_1902_jop_2008_070433
crossref_primary_10_1371_journal_pone_0143779
crossref_primary_10_1038_sj_ijo_0803793
crossref_primary_10_1111_j_1365_2796_2004_01432_x
crossref_primary_10_1038_oby_2008_482
crossref_primary_10_1111_cen_13984
crossref_primary_10_1080_17461391_2011_635701
crossref_primary_10_1007_s11695_016_2477_5
crossref_primary_10_1507_endocrj_K09E_091
crossref_primary_10_1007_s11695_007_9090_6
crossref_primary_10_1038_ejcn_2010_277
crossref_primary_10_1016_j_ijcard_2007_02_015
crossref_primary_10_1155_2012_386524
crossref_primary_10_1002_jcb_21782
crossref_primary_10_1007_s00125_007_0686_0
crossref_primary_10_1007_BF03401293
crossref_primary_10_2515_therapie_2007055
crossref_primary_10_1186_1476_511X_10_198
crossref_primary_10_4158_EP_2017_0086
crossref_primary_10_1210_jc_2004_1696
crossref_primary_10_3844_ajavsp_2010_228_232
crossref_primary_10_3389_fendo_2022_822962
crossref_primary_10_3390_biomedicines8050123
crossref_primary_10_1089_met_2007_0029
crossref_primary_10_1038_oby_2008_555
crossref_primary_10_3109_07435800_2014_920349
crossref_primary_10_1155_2012_389108
crossref_primary_10_1038_s41366_023_01406_1
crossref_primary_10_1038_ijo_2010_216
crossref_primary_10_1210_jc_2009_0431
crossref_primary_10_1038_oby_2005_206
crossref_primary_10_1016_j_semnephrol_2012_12_008
crossref_primary_10_2337_dbi19_0006
crossref_primary_10_1097_FJC_0000000000001131
crossref_primary_10_1590_2359_3997000000316
crossref_primary_10_1016_j_nutres_2013_02_005
crossref_primary_10_1371_journal_pone_0174115
crossref_primary_10_1111_head_12788
crossref_primary_10_1194_jlr_M500212_JLR200
crossref_primary_10_1016_j_hkjn_2012_09_002
crossref_primary_10_1210_jc_2006_0382
crossref_primary_10_1515_hmbci_2015_0042
crossref_primary_10_1155_2017_8494107
crossref_primary_10_1093_gerona_63_4_414
crossref_primary_10_1111_sji_12027
crossref_primary_10_1007_s12170_014_0411_8
crossref_primary_10_1177_0148607108326070
crossref_primary_10_1016_j_cca_2013_02_003
crossref_primary_10_1016_j_clnesp_2018_08_007
crossref_primary_10_1093_bjd_ljac107
crossref_primary_10_1186_1471_2350_10_39
crossref_primary_10_1186_1472_6823_14_7
crossref_primary_10_1002_oby_21028
crossref_primary_10_2337_db10_0483
crossref_primary_10_1152_ajpendo_00240_2005
crossref_primary_10_1007_s11695_008_9424_z
crossref_primary_10_2337_diabetes_55_01_06_db05_1105
crossref_primary_10_1007_s00418_005_0014_z
crossref_primary_10_1016_j_jaci_2012_09_008
crossref_primary_10_1111_j_1467_789X_2005_00159_x
crossref_primary_10_1007_s00424_021_02596_1
crossref_primary_10_3390_antiox9111088
crossref_primary_10_1002_hep_22350
crossref_primary_10_1016_j_neuropharm_2014_12_023
crossref_primary_10_1016_j_dsx_2019_06_005
crossref_primary_10_1210_en_2009_0462
crossref_primary_10_1196_annals_1329_063
crossref_primary_10_1371_journal_pone_0119530
crossref_primary_10_1111_j_1365_2796_2005_01571_x
crossref_primary_10_1186_s12906_016_1278_7
crossref_primary_10_4158_EP_13_7_790
crossref_primary_10_1016_j_atherosclerosis_2007_11_010
crossref_primary_10_1038_oby_2007_97
crossref_primary_10_1111_j_1365_2265_2007_02991_x
crossref_primary_10_1038_oby_2007_263
crossref_primary_10_1097_MCO_0b013e32832c6db7
crossref_primary_10_1152_ajpheart_00907_2011
crossref_primary_10_3390_nu12051305
crossref_primary_10_1371_journal_pone_0084816
crossref_primary_10_18705_1607_419X_2019_25_5_568_576
crossref_primary_10_3389_fimmu_2020_01800
crossref_primary_10_1007_s10616_018_0238_0
crossref_primary_10_1038_sj_ijo_0803138
crossref_primary_10_1002_dmrr_2840
crossref_primary_10_1152_japplphysiol_01080_2011
crossref_primary_10_1038_ijo_2015_15
crossref_primary_10_1038_ijo_2008_163
crossref_primary_10_2527_jas_2008_0971
crossref_primary_10_1042_BJ20091045
crossref_primary_10_1016_j_neurobiolaging_2013_07_022
crossref_primary_10_1017_S2040174417000204
crossref_primary_10_1249_MSS_0000000000000670
crossref_primary_10_1038_oby_2010_23
crossref_primary_10_1007_s11434_014_0386_3
crossref_primary_10_1177_1559827607300283
crossref_primary_10_1530_EJE_07_0213
crossref_primary_10_1111_j_1749_6632_2010_05875_x
crossref_primary_10_1016_j_diabet_2007_09_004
crossref_primary_10_1002_ana_22062
crossref_primary_10_1016_j_jacig_2022_02_003
crossref_primary_10_1152_ajpendo_00068_2015
crossref_primary_10_1007_s40620_014_0070_3
crossref_primary_10_3390_biology12101289
crossref_primary_10_1016_j_jacc_2021_02_070
crossref_primary_10_3923_javaa_2012_637_640
crossref_primary_10_1016_j_regpep_2013_03_027
crossref_primary_10_1038_oby_2009_442
crossref_primary_10_1097_QAD_0b013e3283021a4f
crossref_primary_10_3389_fcvm_2020_00022
crossref_primary_10_1038_sj_ijo_0802983
crossref_primary_10_1007_s00421_011_2073_2
crossref_primary_10_1210_en_2011_0068
crossref_primary_10_3390_biology11111657
crossref_primary_10_18705_1607_419X_2012_18_2_164_176
crossref_primary_10_1152_ajpendo_00506_2005
crossref_primary_10_3389_fendo_2023_1097034
crossref_primary_10_1093_brain_awp208
crossref_primary_10_1016_j_steroids_2011_06_004
crossref_primary_10_1183_09031936_00047010
crossref_primary_10_2337_diacare_28_9_2181
crossref_primary_10_1016_j_trsl_2014_05_008
crossref_primary_10_3390_nu15153453
crossref_primary_10_1016_j_dsx_2013_02_027
crossref_primary_10_1016_j_immbio_2005_12_001
Cites_doi 10.1016/S0026-0495(03)00092-1
10.1055/s-0029-1212086
10.1007/s00125-003-1074-z
10.1136/bmj.322.7288.716
10.2337/diabetes.50.9.2094
10.1016/S0006-291X(03)00090-1
10.1152/ajpendo.00206.2003
10.1530/eje.0.1480657
10.1152/ajpendo.00269.2003
10.1038/90984
10.1006/bbrc.1999.0842
10.1074/jbc.C200251200
10.2337/diacare.26.8.2442
10.1038/sj.ijo.0802367
10.1006/bbrc.2001.5904
10.1055/s-2002-38246
10.1056/NEJM199704103361506
10.1006/bbrc.2001.6307
10.1016/0026-0495(91)90078-B
10.1152/ajpendo.00358.2002
10.2337/diacare.26.6.1745
10.1161/01.CIR.100.25.2473
10.1161/01.ATV.20.6.1595
10.1016/S1043-2760(00)00301-5
10.1152/ajpendo.00110.2003
10.1074/jbc.271.18.10697
10.1161/01.CIR.102.11.1296
10.1093/ajcn/74.3.315
10.1006/bbrc.1999.0255
10.1055/s-2007-978679
10.1210/jc.2002-021600
10.1038/90992
10.1055/s-0037-1613860
10.1111/j.1749-6632.1999.tb07793.x
10.3109/07853899209164137
10.1055/s-2003-39078
10.1161/01.ATV.19.4.972
10.1006/bbrc.1996.0587
ContentType Journal Article
Copyright 2004 Elsevier Ireland Ltd
Copyright 2004 Elsevier Ltd.
Copyright_xml – notice: 2004 Elsevier Ireland Ltd
– notice: Copyright 2004 Elsevier Ltd.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TM
7X8
DOI 10.1016/j.mce.2004.03.002
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Nucleic Acids Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Nucleic Acids Abstracts
MEDLINE - Academic
DatabaseTitleList
Nucleic Acids Abstracts
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1872-8057
EndPage 15
ExternalDocumentID 15149722
10_1016_j_mce_2004_03_002
S030372070400098X
Genre Journal Article
GroupedDBID ---
--K
--M
-~X
.55
.GJ
.~1
0R~
123
1B1
1RT
1~.
1~5
29M
3O-
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
ABBQC
ABFNM
ABFRF
ABGSF
ABJNI
ABLVK
ABMAC
ABMZM
ABUDA
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AHPSJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
DOVZS
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDZ
HLW
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
KOM
LCYCR
LX3
LZ1
M29
M41
MO0
MVM
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SAE
SBG
SCC
SCU
SDF
SDG
SDP
SES
SEW
SPCBC
SSH
SSU
SSZ
T5K
WH7
WUQ
X7M
ZGI
ZXP
~G-
AAHBH
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACIEU
ACRPL
ACVFH
ADCNI
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
PKN
7TM
7X8
ID FETCH-LOGICAL-c446t-9e4b7c385b2f8efd6c97f88cea0928175637f0595e8e2f393aac887fd8edb8283
IEDL.DBID .~1
ISSN 0303-7207
IngestDate Fri Jul 11 12:35:43 EDT 2025
Fri Jul 11 15:50:03 EDT 2025
Wed Feb 19 01:40:16 EST 2025
Thu Apr 24 22:54:57 EDT 2025
Tue Jul 01 03:48:13 EDT 2025
Fri Feb 23 02:19:21 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Obesity
(Human) visceral adipose tissue
(Human) subcutaneous adipose tissue
IL-1β
Gene expression
Adiponectin
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
Copyright 2004 Elsevier Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c446t-9e4b7c385b2f8efd6c97f88cea0928175637f0595e8e2f393aac887fd8edb8283
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 15149722
PQID 21132044
PQPubID 23462
PageCount 7
ParticipantIDs proquest_miscellaneous_71942495
proquest_miscellaneous_21132044
pubmed_primary_15149722
crossref_primary_10_1016_j_mce_2004_03_002
crossref_citationtrail_10_1016_j_mce_2004_03_002
elsevier_sciencedirect_doi_10_1016_j_mce_2004_03_002
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2004-04-30
PublicationDateYYYYMMDD 2004-04-30
PublicationDate_xml – month: 04
  year: 2004
  text: 2004-04-30
  day: 30
PublicationDecade 2000
PublicationPlace Ireland
PublicationPlace_xml – name: Ireland
PublicationTitle Molecular and cellular endocrinology
PublicationTitleAlternate Mol Cell Endocrinol
PublicationYear 2004
Publisher Elsevier Ireland Ltd
Publisher_xml – name: Elsevier Ireland Ltd
References Barnes, Karin (BIB4) 1997; 336
Kubota, Terauchi, Yamauchi, Kubota, Moroi, Matsui, Eto, Yamashita, Kamon, Satoh, Yano, Froguel, Nagai, Kimura, Kadowaki, Noda (BIB26) 2002; 277
Fried, Bunkin, Greenberg (BIB17) 1998; 83
Maeda, Okubo, Shimomura, Funahashi, Matsuzawa, Matsubara (BIB29) 1996; 221
Seidell, Perusse, Despres, Bouchard (BIB36) 2001; 74
Ouchi, Kihara, Arita, Okamoto, Maeda, Kuriyama, Hotta, Nishida, Takahashi, Muraguchi, Ohmoto, Nakamura, Yamashita, Funahashi, Matsuzawa (BIB34) 2000; 102
Berg, Combs, Du, Brownlee, Scherer (BIB5) 2001; 7
Lihn, Ostergard, Nyholm, Pedersen, Richelsen, Schmitz (BIB27) 2003; 284
Maeda, Takahashi, Funahashi, Kihara, Nishizawa, Kishida, Nagaretani, Matsuda, Komuro, Ouchi, Kuriyama, Hotta, Nakamura, Shimomura, Matsuzawa (BIB30) 2001; 50
Despres, Lemieux, Prud’homme (BIB12) 2001; 322
Fisher, McTernan, Valsamakis, Chetty, Harte, Anwar, Starcynski, Crocker, Barnett, McTernan, Kumar (BIB16) 2002; 34
Krakoff, Funahashi, Stehouwer, Schalkwijk, Tanaka, Matsuzawa, Kobes, Tataranni, Hanson, Knowler, Lindsay (BIB24) 2003; 26
Hotta, Funahashi, Arita, Takahashi, Matsuda, Okamoto, Iwahashi, Kuriyama, Ouchi, Maeda, Nishida, Kihara, Sakai, Nakajima, Hasegawa, Muraguchi, Ohmoto, Nakamura, Yamashita, Hanafusa, Matsuzawa (BIB22) 2000; 20
Arita, Kihara, Ouchi, Takahashi, Maeda, Miyagawa, Hotta, Shimomura, Nakamura, Miyaoka, Kuriyama, Nishida, Yamashita, Okubo, Matsubara, Muraguchi, Ohmoto, Funahashi, Matsuzawa (BIB3) 1999; 257
Yang, Chen, Lee, Lee, Chao, Huang, Chen, Tai, Chuang (BIB39) 2003; 27
Fasshauer, Kralisch, Klier, Lossner, Bluher, Klein, Paschke (BIB15) 2003; 301
Hotamisligil (BIB21) 1999; 107
He, Pedersen, Bruun, Lihn, Jensen, Richelsen (BIB19) 2003; 35
Altomonte, Harbaran, Richter, Dong (BIB2) 2003; 52
Bjorntorp (BIB6) 1992; 24
Bruun, J.M., Lihn, A.S., Madan, A.K., Pedersen, S.B., Schiott, K.M., Fain, J.N., Richelsen, B., 2004. Higher production of interleukin-8 in visceral compared to subcutaneous adipose tissue. Implications of non-adipose cells in adipose tissue. Am. J. Physiol. Endocrinol. Metab. 286, E8–E13.
Ouchi, Kihara, Arita, Maeda, Kuriyama, Okamoto, Hotta, Nishida, Takahashi, Nakamura, Yamashita, Funahashi, Matsuzawa (BIB33) 1999; 100
Kristensen, Pedersen, Richelsen (BIB25) 1999; 259
Eriksson, Van, Hoffstedt, Lundquist, Vidal, Stemme, Hamsten, Arner, Reynisdottir (BIB13) 2000; 83
Cnop, Havel, Utzschneider, Carr, Sinha, Boyko, Retzlaff, Knopp, Brunzell, Kahn (BIB11) 2003; 46
Yudkin, Stehouwer, Emeis, Coppack (BIB40) 1999; 19
Ahima, Flier (BIB1) 2000; 11
Matsubara, Namioka, Katayose (BIB31) 2003; 148
Tong, Sankale, Hadigan, Tan, Rosenberg, Kanki, Grinspoon, Hotamisligil (BIB37) 2003; 88
Halleux, Takahashi, Delporte, Detry, Funahashi, Matsuzawa, Brichard (BIB18) 2001; 288
Matsuzawa, Funahashi, Nakamura (BIB32) 1999; 892
Hu, Liang, Spiegelman (BIB23) 1996; 271
Chandran, Phillips, Ciaraldi, Henry (BIB10) 2003; 26
Richelsen, Pedersen, Moller-Pedersen, Bak (BIB35) 1991; 40
He, Pedersen, Bruun, Richelsen (BIB20) 2000; 32
Bruun, Lihn, Verdich, Pedersen, Toubro, Astrup, Richelsen (BIB8) 2003; 285
Fasshauer, Klein, Neumann, Eszlinger, Paschke (BIB14) 2002; 290
Lihn, Richelsen, Pedersen, Haugaard, Rathje, Madsbad, Andersen (BIB28) 2003; 285
Bruun, Pedersen, Richelsen (BIB9) 2001; 86
Yamauchi, Kamon, Waki, Terauchi, Kubota, Hara, Mori, Ide, Murakami, Tsuboyama-Kasaoka, Ezaki, Akanuma, Gavrilova, Vinson, Reitman, Kagechika, Shudo, Yoda, Nakano, Tobe, Nagai, Kimura, Tomita, Froguel, Kadowaki (BIB38) 2001; 7
Ahima (10.1016/j.mce.2004.03.002_BIB1) 2000; 11
Halleux (10.1016/j.mce.2004.03.002_BIB18) 2001; 288
Tong (10.1016/j.mce.2004.03.002_BIB37) 2003; 88
10.1016/j.mce.2004.03.002_BIB7
Seidell (10.1016/j.mce.2004.03.002_BIB36) 2001; 74
Fisher (10.1016/j.mce.2004.03.002_BIB16) 2002; 34
Cnop (10.1016/j.mce.2004.03.002_BIB11) 2003; 46
Fasshauer (10.1016/j.mce.2004.03.002_BIB14) 2002; 290
He (10.1016/j.mce.2004.03.002_BIB19) 2003; 35
Kubota (10.1016/j.mce.2004.03.002_BIB26) 2002; 277
Hu (10.1016/j.mce.2004.03.002_BIB23) 1996; 271
Eriksson (10.1016/j.mce.2004.03.002_BIB13) 2000; 83
Krakoff (10.1016/j.mce.2004.03.002_BIB24) 2003; 26
Chandran (10.1016/j.mce.2004.03.002_BIB10) 2003; 26
Hotta (10.1016/j.mce.2004.03.002_BIB22) 2000; 20
Fried (10.1016/j.mce.2004.03.002_BIB17) 1998; 83
Yang (10.1016/j.mce.2004.03.002_BIB39) 2003; 27
Ouchi (10.1016/j.mce.2004.03.002_BIB33) 1999; 100
Despres (10.1016/j.mce.2004.03.002_BIB12) 2001; 322
Altomonte (10.1016/j.mce.2004.03.002_BIB2) 2003; 52
Kristensen (10.1016/j.mce.2004.03.002_BIB25) 1999; 259
Lihn (10.1016/j.mce.2004.03.002_BIB27) 2003; 284
Ouchi (10.1016/j.mce.2004.03.002_BIB34) 2000; 102
Hotamisligil (10.1016/j.mce.2004.03.002_BIB21) 1999; 107
Bjorntorp (10.1016/j.mce.2004.03.002_BIB6) 1992; 24
Maeda (10.1016/j.mce.2004.03.002_BIB29) 1996; 221
Barnes (10.1016/j.mce.2004.03.002_BIB4) 1997; 336
Berg (10.1016/j.mce.2004.03.002_BIB5) 2001; 7
Matsubara (10.1016/j.mce.2004.03.002_BIB31) 2003; 148
Yamauchi (10.1016/j.mce.2004.03.002_BIB38) 2001; 7
Maeda (10.1016/j.mce.2004.03.002_BIB30) 2001; 50
Lihn (10.1016/j.mce.2004.03.002_BIB28) 2003; 285
Richelsen (10.1016/j.mce.2004.03.002_BIB35) 1991; 40
Matsuzawa (10.1016/j.mce.2004.03.002_BIB32) 1999; 892
He (10.1016/j.mce.2004.03.002_BIB20) 2000; 32
Arita (10.1016/j.mce.2004.03.002_BIB3) 1999; 257
Bruun (10.1016/j.mce.2004.03.002_BIB9) 2001; 86
Fasshauer (10.1016/j.mce.2004.03.002_BIB15) 2003; 301
Bruun (10.1016/j.mce.2004.03.002_BIB8) 2003; 285
Yudkin (10.1016/j.mce.2004.03.002_BIB40) 1999; 19
References_xml – volume: 11
  start-page: 327
  year: 2000
  end-page: 332
  ident: BIB1
  article-title: Adipose tissue as an endocrine organ
  publication-title: Trends Endocrinol. Metab.
– volume: 148
  start-page: 657
  year: 2003
  end-page: 662
  ident: BIB31
  article-title: Decreased plasma adiponectin concentrations in women with low grade C-reactive protein elevation
  publication-title: Eur. J. Endocrinol.
– volume: 19
  start-page: 972
  year: 1999
  end-page: 978
  ident: BIB40
  article-title: C-reactive protein in healthy subjects—associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 83
  start-page: 847
  year: 1998
  end-page: 850
  ident: BIB17
  article-title: Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 74
  start-page: 315
  year: 2001
  end-page: 321
  ident: BIB36
  article-title: Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec family study
  publication-title: Am. J. Clin. Nutr.
– volume: 7
  start-page: 947
  year: 2001
  end-page: 953
  ident: BIB5
  article-title: The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
  publication-title: Nat. Med.
– volume: 290
  start-page: 1084
  year: 2002
  end-page: 1089
  ident: BIB14
  article-title: Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 7
  start-page: 941
  year: 2001
  end-page: 946
  ident: BIB38
  article-title: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
  publication-title: Nat. Med.
– volume: 301
  start-page: 1045
  year: 2003
  end-page: 1050
  ident: BIB15
  article-title: Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 259
  start-page: 624
  year: 1999
  end-page: 630
  ident: BIB25
  article-title: Regulation of leptin by steroid hormones in rat adipose tissue
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 26
  start-page: 2442
  year: 2003
  end-page: 2450
  ident: BIB10
  article-title: Adiponectin: more than just another fat cell hormone?
  publication-title: Diab. Care
– volume: 107
  start-page: 119
  year: 1999
  end-page: 125
  ident: BIB21
  article-title: Mechanisms of TNF-alpha-induced insulin resistance
  publication-title: Exp. Clin. Endocrinol. Diab.
– volume: 24
  start-page: 3
  year: 1992
  end-page: 5
  ident: BIB6
  article-title: Metabolic abnormalities in visceral obesity
  publication-title: Ann. Med.
– volume: 285
  start-page: E527
  year: 2003
  end-page: E533
  ident: BIB8
  article-title: Regulation of adiponectin by adipose tissue-derived cytokines:
  publication-title: Am. J. Physiol. Endocrinol. Metab.
– volume: 277
  start-page: 25863
  year: 2002
  end-page: 25866
  ident: BIB26
  article-title: Disruption of adiponectin causes insulin resistance and neointimal formation
  publication-title: J. Biol. Chem.
– volume: 322
  start-page: 716
  year: 2001
  end-page: 720
  ident: BIB12
  article-title: Treatment of obesity: need to focus on high risk abdominally obese patients
  publication-title: BMJ
– volume: 88
  start-page: 1559
  year: 2003
  end-page: 1564
  ident: BIB37
  article-title: Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 26
  start-page: 1745
  year: 2003
  end-page: 1751
  ident: BIB24
  article-title: Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian
  publication-title: Diabetes Care
– volume: 35
  start-page: 178
  year: 2003
  end-page: 182
  ident: BIB19
  article-title: Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects
  publication-title: Horm. Metab. Res.
– volume: 271
  start-page: 10697
  year: 1996
  end-page: 10703
  ident: BIB23
  article-title: AdipoQ is a novel adipose-specific gene dysregulated in obesity
  publication-title: J. Biol. Chem.
– volume: 83
  start-page: 545
  year: 2000
  end-page: 548
  ident: BIB13
  article-title: Regional variation in plasminogen activator inhibitor-1 expression in adipose tissue from obese individuals
  publication-title: Thromb. Haemost.
– volume: 40
  start-page: 990
  year: 1991
  end-page: 996
  ident: BIB35
  article-title: Regional differences in triglyceride breakdown in human adipose tissue: effects of catecholamines, insulin, and prostaglandin E2
  publication-title: Metabolism
– volume: 100
  start-page: 2473
  year: 1999
  end-page: 2476
  ident: BIB33
  article-title: Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin
  publication-title: Circulation
– volume: 892
  start-page: 146
  year: 1999
  end-page: 154
  ident: BIB32
  article-title: Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances
  publication-title: Ann. NY Acad. Sci.
– volume: 102
  start-page: 1296
  year: 2000
  end-page: 1301
  ident: BIB34
  article-title: Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappa B signaling through a cAMP-dependent pathway
  publication-title: Circulation
– volume: 52
  start-page: 958
  year: 2003
  end-page: 963
  ident: BIB2
  article-title: Fat depot-specific expression of adiponectin is impaired in Zucker fatty rats
  publication-title: Metabolism
– volume: 221
  start-page: 286
  year: 1996
  end-page: 289
  ident: BIB29
  article-title: cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1)
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 27
  start-page: 896
  year: 2003
  end-page: 900
  ident: BIB39
  article-title: Adiponectin mRNA levels in the abdominal adipose depots of nondiabetic women
  publication-title: Int. J. Obes. Relat. Metab. Disord.
– volume: 34
  start-page: 650
  year: 2002
  end-page: 654
  ident: BIB16
  article-title: Differences in adiponectin protein expression: effect of fat depots and type 2 diabetic status
  publication-title: Horm. Metab. Res.
– volume: 20
  start-page: 1595
  year: 2000
  end-page: 1599
  ident: BIB22
  article-title: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 257
  start-page: 79
  year: 1999
  end-page: 83
  ident: BIB3
  article-title: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 86
  start-page: 1267
  year: 2001
  end-page: 1273
  ident: BIB9
  article-title: Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 50
  start-page: 2094
  year: 2001
  end-page: 2099
  ident: BIB30
  article-title: PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein
  publication-title: Diabetes
– volume: 284
  start-page: E443
  year: 2003
  end-page: E448
  ident: BIB27
  article-title: Adiponectin expression in adipose tissue is reduced in first-degree relatives of type 2 diabetic patients
  publication-title: Am. J. Physiol. Endocrinol. Metab.
– volume: 46
  start-page: 459
  year: 2003
  end-page: 469
  ident: BIB11
  article-title: Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex
  publication-title: Diabetologia
– reference: Bruun, J.M., Lihn, A.S., Madan, A.K., Pedersen, S.B., Schiott, K.M., Fain, J.N., Richelsen, B., 2004. Higher production of interleukin-8 in visceral compared to subcutaneous adipose tissue. Implications of non-adipose cells in adipose tissue. Am. J. Physiol. Endocrinol. Metab. 286, E8–E13.
– volume: 32
  start-page: 515
  year: 2000
  end-page: 520
  ident: BIB20
  article-title: Regulation of plasminogen activitor inhibitor-1 in human adipose tissue: interaction between cytokines, cortisol and estrogen
  publication-title: Horm. Metab. Res.
– volume: 285
  start-page: E1072
  year: 2003
  end-page: E1080
  ident: BIB28
  article-title: Increased expression of adipose tissue cytokines in HIV-associated lipodystrophy. Implications for the reduced expression and plasma levels of adiponectin
  publication-title: Am. J. Physiol. Endocrinol. Metab.
– volume: 288
  start-page: 1102
  year: 2001
  end-page: 1107
  ident: BIB18
  article-title: Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 336
  start-page: 1066
  year: 1997
  end-page: 1071
  ident: BIB4
  article-title: Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases
  publication-title: N. Engl. J. Med.
– volume: 52
  start-page: 958
  year: 2003
  ident: 10.1016/j.mce.2004.03.002_BIB2
  article-title: Fat depot-specific expression of adiponectin is impaired in Zucker fatty rats
  publication-title: Metabolism
  doi: 10.1016/S0026-0495(03)00092-1
– volume: 107
  start-page: 119
  year: 1999
  ident: 10.1016/j.mce.2004.03.002_BIB21
  article-title: Mechanisms of TNF-alpha-induced insulin resistance
  publication-title: Exp. Clin. Endocrinol. Diab.
  doi: 10.1055/s-0029-1212086
– volume: 46
  start-page: 459
  year: 2003
  ident: 10.1016/j.mce.2004.03.002_BIB11
  article-title: Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex
  publication-title: Diabetologia
  doi: 10.1007/s00125-003-1074-z
– volume: 322
  start-page: 716
  year: 2001
  ident: 10.1016/j.mce.2004.03.002_BIB12
  article-title: Treatment of obesity: need to focus on high risk abdominally obese patients
  publication-title: BMJ
  doi: 10.1136/bmj.322.7288.716
– volume: 50
  start-page: 2094
  year: 2001
  ident: 10.1016/j.mce.2004.03.002_BIB30
  article-title: PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein
  publication-title: Diabetes
  doi: 10.2337/diabetes.50.9.2094
– volume: 301
  start-page: 1045
  year: 2003
  ident: 10.1016/j.mce.2004.03.002_BIB15
  article-title: Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/S0006-291X(03)00090-1
– volume: 285
  start-page: E1072
  year: 2003
  ident: 10.1016/j.mce.2004.03.002_BIB28
  article-title: Increased expression of adipose tissue cytokines in HIV-associated lipodystrophy. Implications for the reduced expression and plasma levels of adiponectin
  publication-title: Am. J. Physiol. Endocrinol. Metab.
  doi: 10.1152/ajpendo.00206.2003
– volume: 148
  start-page: 657
  year: 2003
  ident: 10.1016/j.mce.2004.03.002_BIB31
  article-title: Decreased plasma adiponectin concentrations in women with low grade C-reactive protein elevation
  publication-title: Eur. J. Endocrinol.
  doi: 10.1530/eje.0.1480657
– ident: 10.1016/j.mce.2004.03.002_BIB7
  doi: 10.1152/ajpendo.00269.2003
– volume: 7
  start-page: 941
  year: 2001
  ident: 10.1016/j.mce.2004.03.002_BIB38
  article-title: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
  publication-title: Nat. Med.
  doi: 10.1038/90984
– volume: 259
  start-page: 624
  year: 1999
  ident: 10.1016/j.mce.2004.03.002_BIB25
  article-title: Regulation of leptin by steroid hormones in rat adipose tissue
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1006/bbrc.1999.0842
– volume: 277
  start-page: 25863
  year: 2002
  ident: 10.1016/j.mce.2004.03.002_BIB26
  article-title: Disruption of adiponectin causes insulin resistance and neointimal formation
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.C200251200
– volume: 26
  start-page: 2442
  year: 2003
  ident: 10.1016/j.mce.2004.03.002_BIB10
  article-title: Adiponectin: more than just another fat cell hormone?
  publication-title: Diab. Care
  doi: 10.2337/diacare.26.8.2442
– volume: 83
  start-page: 847
  year: 1998
  ident: 10.1016/j.mce.2004.03.002_BIB17
  article-title: Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 27
  start-page: 896
  year: 2003
  ident: 10.1016/j.mce.2004.03.002_BIB39
  article-title: Adiponectin mRNA levels in the abdominal adipose depots of nondiabetic women
  publication-title: Int. J. Obes. Relat. Metab. Disord.
  doi: 10.1038/sj.ijo.0802367
– volume: 288
  start-page: 1102
  year: 2001
  ident: 10.1016/j.mce.2004.03.002_BIB18
  article-title: Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1006/bbrc.2001.5904
– volume: 34
  start-page: 650
  year: 2002
  ident: 10.1016/j.mce.2004.03.002_BIB16
  article-title: Differences in adiponectin protein expression: effect of fat depots and type 2 diabetic status
  publication-title: Horm. Metab. Res.
  doi: 10.1055/s-2002-38246
– volume: 336
  start-page: 1066
  year: 1997
  ident: 10.1016/j.mce.2004.03.002_BIB4
  article-title: Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJM199704103361506
– volume: 290
  start-page: 1084
  year: 2002
  ident: 10.1016/j.mce.2004.03.002_BIB14
  article-title: Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1006/bbrc.2001.6307
– volume: 40
  start-page: 990
  year: 1991
  ident: 10.1016/j.mce.2004.03.002_BIB35
  article-title: Regional differences in triglyceride breakdown in human adipose tissue: effects of catecholamines, insulin, and prostaglandin E2
  publication-title: Metabolism
  doi: 10.1016/0026-0495(91)90078-B
– volume: 284
  start-page: E443
  year: 2003
  ident: 10.1016/j.mce.2004.03.002_BIB27
  article-title: Adiponectin expression in adipose tissue is reduced in first-degree relatives of type 2 diabetic patients
  publication-title: Am. J. Physiol. Endocrinol. Metab.
  doi: 10.1152/ajpendo.00358.2002
– volume: 26
  start-page: 1745
  year: 2003
  ident: 10.1016/j.mce.2004.03.002_BIB24
  article-title: Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian
  publication-title: Diabetes Care
  doi: 10.2337/diacare.26.6.1745
– volume: 100
  start-page: 2473
  year: 1999
  ident: 10.1016/j.mce.2004.03.002_BIB33
  article-title: Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin
  publication-title: Circulation
  doi: 10.1161/01.CIR.100.25.2473
– volume: 20
  start-page: 1595
  year: 2000
  ident: 10.1016/j.mce.2004.03.002_BIB22
  article-title: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/01.ATV.20.6.1595
– volume: 11
  start-page: 327
  year: 2000
  ident: 10.1016/j.mce.2004.03.002_BIB1
  article-title: Adipose tissue as an endocrine organ
  publication-title: Trends Endocrinol. Metab.
  doi: 10.1016/S1043-2760(00)00301-5
– volume: 285
  start-page: E527
  year: 2003
  ident: 10.1016/j.mce.2004.03.002_BIB8
  article-title: Regulation of adiponectin by adipose tissue-derived cytokines: In vivo and in vitro investigations in humans
  publication-title: Am. J. Physiol. Endocrinol. Metab.
  doi: 10.1152/ajpendo.00110.2003
– volume: 271
  start-page: 10697
  year: 1996
  ident: 10.1016/j.mce.2004.03.002_BIB23
  article-title: AdipoQ is a novel adipose-specific gene dysregulated in obesity
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.271.18.10697
– volume: 102
  start-page: 1296
  year: 2000
  ident: 10.1016/j.mce.2004.03.002_BIB34
  article-title: Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappa B signaling through a cAMP-dependent pathway
  publication-title: Circulation
  doi: 10.1161/01.CIR.102.11.1296
– volume: 74
  start-page: 315
  year: 2001
  ident: 10.1016/j.mce.2004.03.002_BIB36
  article-title: Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec family study
  publication-title: Am. J. Clin. Nutr.
  doi: 10.1093/ajcn/74.3.315
– volume: 257
  start-page: 79
  year: 1999
  ident: 10.1016/j.mce.2004.03.002_BIB3
  article-title: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1006/bbrc.1999.0255
– volume: 32
  start-page: 515
  year: 2000
  ident: 10.1016/j.mce.2004.03.002_BIB20
  article-title: Regulation of plasminogen activitor inhibitor-1 in human adipose tissue: interaction between cytokines, cortisol and estrogen
  publication-title: Horm. Metab. Res.
  doi: 10.1055/s-2007-978679
– volume: 86
  start-page: 1267
  year: 2001
  ident: 10.1016/j.mce.2004.03.002_BIB9
  article-title: Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 88
  start-page: 1559
  year: 2003
  ident: 10.1016/j.mce.2004.03.002_BIB37
  article-title: Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2002-021600
– volume: 7
  start-page: 947
  year: 2001
  ident: 10.1016/j.mce.2004.03.002_BIB5
  article-title: The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
  publication-title: Nat. Med.
  doi: 10.1038/90992
– volume: 83
  start-page: 545
  year: 2000
  ident: 10.1016/j.mce.2004.03.002_BIB13
  article-title: Regional variation in plasminogen activator inhibitor-1 expression in adipose tissue from obese individuals
  publication-title: Thromb. Haemost.
  doi: 10.1055/s-0037-1613860
– volume: 892
  start-page: 146
  year: 1999
  ident: 10.1016/j.mce.2004.03.002_BIB32
  article-title: Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances
  publication-title: Ann. NY Acad. Sci.
  doi: 10.1111/j.1749-6632.1999.tb07793.x
– volume: 24
  start-page: 3
  year: 1992
  ident: 10.1016/j.mce.2004.03.002_BIB6
  article-title: Metabolic abnormalities in visceral obesity
  publication-title: Ann. Med.
  doi: 10.3109/07853899209164137
– volume: 35
  start-page: 178
  year: 2003
  ident: 10.1016/j.mce.2004.03.002_BIB19
  article-title: Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects
  publication-title: Horm. Metab. Res.
  doi: 10.1055/s-2003-39078
– volume: 19
  start-page: 972
  year: 1999
  ident: 10.1016/j.mce.2004.03.002_BIB40
  article-title: C-reactive protein in healthy subjects—associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/01.ATV.19.4.972
– volume: 221
  start-page: 286
  year: 1996
  ident: 10.1016/j.mce.2004.03.002_BIB29
  article-title: cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1)
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1006/bbrc.1996.0587
SSID ssj0007528
Score 2.251869
Snippet Adiponectin is an adipocyte-specific protein suggested to play a role in mediating the metabolic effects of obesity. In the present study, we investigated...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 9
SubjectTerms (Human) subcutaneous adipose tissue
(Human) visceral adipose tissue
Adiponectin
Adipose Tissue - metabolism
Adult
Female
Gene expression
Gene Expression - drug effects
Humans
IL-1β
Intercellular Signaling Peptides and Proteins - biosynthesis
Intercellular Signaling Peptides and Proteins - genetics
Interleukin-1 - pharmacology
Middle Aged
Obesity
Obesity - genetics
Obesity - metabolism
RNA, Messenger - metabolism
Title Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects
URI https://dx.doi.org/10.1016/j.mce.2004.03.002
https://www.ncbi.nlm.nih.gov/pubmed/15149722
https://www.proquest.com/docview/21132044
https://www.proquest.com/docview/71942495
Volume 219
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxEB5VRUJcELQ8QqH4gDggLdna3rV9jCqq8GgOQKWIi-X12lJQsonYpIILv50Z7y4Vh_TAaaX1WLI8o5lv7M8zAK9yVyIu9jpTIphMli5mGGdcVgpPt2ZU4IXeDl_OyumV_DAv5gdwPryFIVpl7_s7n568df9n3O_meLNYjL-geVKLFUVmmBs9pxfsUpGVv_19Q_NQReqvSsIZSQ83m4njtfKpUqbs6pzyfbFpH_ZMMejiAdzvwSObdOt7CAehOYLjSYOJ8-oXe80SnTOdkx_B3cv-1vwYvn2iVmgs_OxJrw1bR-bqxWbdkLtr2OrzbMLwe71oPZ1RdYNtYNukFhpaBtcw19RsXQUcaHcVHeC0j-Dq4t3X82nW91TIPCZ-28wEWSkvdFHxqEOsS29U1NoHlxuuEUuUQkWEXEXQgUdhhHMe_VCsdagrzM7EYzhscHVPgZVe8lQgv0YQc1ZFE6XTuoi6cL7OAx9BPuym9X3Bcep7sbQDs-y7RQVQI0xpc2FRASN483fKpqu2cZuwHFRk_zEZi9HgtmkvB3XaFW3rkljF611rMRcWPJdyv4Q6M5KadY_gSWcHN6tE4GkU58_-b1EncG-gBIn8ORxuf-zCC0Q72-o0mfMp3Jm8_zid_QF5V_x2
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEB4tiwRcEOzyKK_1AXFACs3aTmIfqxWrAm0PsCtVXCzHsaWiNq027Qou_HZmnIQVh-6BU6R4Io08k5nP9ng-gLepzREXO5UUwutE5jYkmGdskgtHp2bU4IXuDk9n-fhSfp5n8wM46-_CUFllF_vbmB6jdfdm2M3mcLNYDL-hexLFSkFumGo1vwN3Jf6-RGPw4fdNnUeRRYJVkk5IvD_ajEVeKxdbZcq20Snfl5z2gc-YhM4fwcMOPbJRq-BjOPD1ERyPalw5r36xdyzWc8aN8iO4N-2OzY_h-4S40Jj_2VW91mwdmK0Wm3VN8a5mq6-zEcPn9aJxtEnVDjaebaNdaGjpbc1sXbF16XGg2ZW0g9M8gcvzjxdn46QjVUgcrvy2ifayLJxQWcmD8qHKnS6CUs7bVHOFYCIXRUDMlXnleRBaWOswEIVK-arE5Zl4Coc1avccWO4kjx3yK0Qxp2XQQVqlsqAy66rU8wGk_Wwa13UcJ-KLpelLy34YNAAxYUqTCoMGGMD7v59s2nYbtwnL3kTmH58xmA5u--ykN6dZ0bQuqax4vWsMLoYFT6XcL1Gcakls3QN41vrBjZaIPHXB-Yv_U-oE7o8vphMz-TT78hIe9PVBIn0Fh9urnX-N0Gdbvomu_Qc0a_4E
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Lower+expression+of+adiponectin+mRNA+in+visceral+adipose+tissue+in+lean+and+obese+subjects&rft.jtitle=Molecular+and+cellular+endocrinology&rft.au=Lihn%2C+Aina+S&rft.au=Bruun%2C+Jens+M&rft.au=He%2C+Gengsheng&rft.au=Pedersen%2C+Steen+B&rft.date=2004-04-30&rft.issn=0303-7207&rft.volume=219&rft.issue=1-2&rft.spage=9&rft_id=info:doi/10.1016%2Fj.mce.2004.03.002&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0303-7207&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0303-7207&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0303-7207&client=summon